{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:35:34Z","timestamp":1762101334962},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clim.2012.07.016","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T23:00:51Z","timestamp":1344294051000},"page":"102-107","source":"Crossref","is-referenced-by-count":30,"title":["Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110"],"prefix":"10.1016","volume":"145","author":[{"given":"Tiffany","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peck","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Roscioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon T.","family":"Cliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.07.016_bb0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(76)80988-2","article-title":"Familial hepatic venoocclusive disease with probable immune deficiency","volume":"88","author":"Mellis","year":"1976","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2012.07.016_bb0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3476(87)80546-2","article-title":"Defective humoral and cellular immune functions associated with veno-occlusive disease of the liver","volume":"110","author":"Etzioni","year":"1987","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2012.07.016_bb0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ng1780","article-title":"Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease","volume":"38","author":"Roscioli","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.07.016_bb0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/bies.20089","article-title":"PML nuclear bodies: dynamic sensors of DNA damage and cellular stress","volume":"26","author":"Dellaire","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.clim.2012.07.016_bb0025","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1073\/pnas.95.13.7316","article-title":"Interaction of PS100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment","volume":"95","author":"Seeler","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"18","key":"10.1016\/j.clim.2012.07.016_bb0030","first-page":"12555","article-title":"The nuclear dot protein SP100 characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers*","volume":"247","author":"Sternsdof","year":"1999","journal-title":"J. Biochem."},{"key":"10.1016\/j.clim.2012.07.016_bb0035","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/MCB.20.16.6138-6146.2000","article-title":"Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator","volume":"20","author":"Bloch","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"17","key":"10.1016\/j.clim.2012.07.016_bb0040","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1128\/JVI.78.17.9412-9422.2004","article-title":"Epstein\u2013Barr (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression","volume":"70","author":"Nicewonger","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2012.07.016_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.02.054","article-title":"Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome","author":"Cliffe","year":"2012","journal-title":"Alr. Clin. Immun."},{"key":"10.1016\/j.clim.2012.07.016_bb0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0022-3476(99)70301-X","article-title":"Hepatic veno-occlusive disease in ataxia-telangiectasia","volume":"134","author":"Srisirirojanakorn","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2012.07.016_bb0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","article-title":"Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors","volume":"22","author":"Hasegawa","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2012.07.016_bb0060","series-title":"Gene Reviews","article-title":"Hepatic veno-occlusive disease with immunodeficiency","author":"Roscioli","year":"2010"},{"key":"10.1016\/j.clim.2012.07.016_bb0065","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2012.07.016_bb0070","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1204854","article-title":"Role and fate of PML nuclear bodies in response to interferon and viral infections","volume":"20","author":"Regad","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2012.07.016_bb0075","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/MCB.20.16.6138-6146.2000","article-title":"Sp110 localized to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator","volume":"20","author":"Bloch","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2012.07.016_bb0080","series-title":"12th Meeting of the European Society for Immunodeficiencies","article-title":"Hepatic veno-occlusive disease with immunodeficincy syndorme case report","author":"Ruga","year":"2006"},{"key":"10.1016\/j.clim.2012.07.016_bb0085","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1182\/blood-2003-07-2209","article-title":"Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes","volume":"103","author":"Turhan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2012.07.016_bb0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.iac.2008.01.006","article-title":"Advances in hematopoietic stem cell transplantation for primary immunodeficiency","volume":"28","author":"Gennery","year":"2008","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.clim.2012.07.016_bb0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2009.05.009","article-title":"Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury","volume":"137","author":"Harb","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2012.07.016_bb0100","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.clim.2012.07.016_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2005.02.015","article-title":"Venous occlusive disease in children","volume":"118","author":"Gharib","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2012.07.016_bb0110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children","volume":"48","author":"Bulley","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.clim.2012.07.016_bb0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatr. Blood Cancer"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T11:46:04Z","timestamp":1562067964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161200191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S152166161200191X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.07.016","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}